Reaction

Superinfection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,482 reports · 42 co-occurring drugs

As of the last recalculation, Superinfection appears in 1,482 FAERS reports alongside 42 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 76.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	71	76.8	77.2
Dornase Alfa	69	51.8	52.0
Eplerenone	34	38.1	38.2
Dextrose	33	36.0	36.1
Dextrose Monohydrate	33	35.4	35.5
Cefuroxime	28	35.0	35.1
Sennosides 8.6 Mg Tablets	38	26.1	26.2
Senna	38	26.0	26.0
Senna Leaf	41	25.6	25.7
Trimethoprim	20	24.1	24.2
Clarithromycin	56	23.8	23.8
Phenobarbital	24	23.6	23.7
Vancomycin Hydrochloride	92	20.8	20.9
Vancomycin	79	20.2	20.2
Rifampicin	14	19.6	19.6
Sennosides	40	19.3	19.3
Mepolizumab	64	18.9	18.9
Fondaparinux Sodium	10	17.5	17.5
Exemestane	26	17.3	17.4
Budesonide	69	17.2	17.2
Salmeterol Xinafoate	10	16.4	16.4
Phenytoin	21	14.3	14.3
Midazolam Hydrochloride	24	12.7	12.7
Propofol	31	12.2	12.2
Anastrozole Tablets	18	11.9	11.9
Fulvestrant	27	11.7	11.7
Lacosamide	29	11.1	11.2
Mercaptopurine	13	10.6	10.6
Midazolam	18	10.1	10.1
Cetuximab	22	10.0	10.0
Valproic Acid	22	9.9	9.9
Tofacitinib Citrate	9	9.7	9.7
Baricitinib	6	8.8	8.8
Letrozole Tablets	26	7.7	7.7
Palivizumab	8	7.3	7.4
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	4	6.9	6.9
Botulinum Toxin Type A	6	6.8	6.8
Panitumumab	7	6.3	6.3
Erlotinib	4	5.8	5.8
Azacitidine For	7	5.4	5.4
Remdesivir	5	5.3	5.3
Olaparib	6	4.0	4.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.